AAAAAA

   
Results: 1-12 |
Results: 12
Trends in pubertal development in Europe
Authors: Keizer-Schrama, SMPFD Mul, D
Citation: Smpfd. Keizer-schrama et D. Mul, Trends in pubertal development in Europe, HUM REP UPD, 7(3), 2001, pp. 287-291
Trends in pubertal development in Europe
Authors: Keizer-Schrama, SMPFD Mul, D
Citation: Smpfd. Keizer-schrama et D. Mul, Trends in pubertal development in Europe, APMIS, 109, 2001, pp. S164-S168
Psychological assessments before and after treatment of early puberty in adopted children
Authors: Mul, D Versluis-den Bieman, HJM Slijper, FME Oostdijk, W Waelkens, JJJ Drop, SLS
Citation: D. Mul et al., Psychological assessments before and after treatment of early puberty in adopted children, ACT PAEDIAT, 90(9), 2001, pp. 965-971
Growth hormone in short children: beyond medicine?
Authors: Bolt, LLE Mul, D
Citation: Lle. Bolt et D. Mul, Growth hormone in short children: beyond medicine?, ACT PAEDIAT, 90(1), 2001, pp. 69-73
The relationship between impairments in joint function and disabilities inindependent function in children with systemic juvenile idiopathic arthritis
Authors: Bekkering, WP ten Cate, R van Suijlekom-Smit, LWA Mul, D van der Velde, EA van den Ende, CHM
Citation: Wp. Bekkering et al., The relationship between impairments in joint function and disabilities inindependent function in children with systemic juvenile idiopathic arthritis, J RHEUMATOL, 28(5), 2001, pp. 1099-1105
Gonadotrophin releasing hormone agonist with or without recombinant human GH in children with early puberty
Authors: Mul, D Oostdijk, W Waelkens, JJJ Schulpen, TWJ Drop, SLS
Citation: D. Mul et al., Gonadotrophin releasing hormone agonist with or without recombinant human GH in children with early puberty, CLIN ENDOCR, 55(1), 2001, pp. 121-129
Pubertal development in the Netherlands 1965-1997
Authors: Mul, D Fredriks, AM van Buuren, S Oostdijk, W Verloove-Vanhorick, SP Wit, JM
Citation: D. Mul et al., Pubertal development in the Netherlands 1965-1997, PEDIAT RES, 50(4), 2001, pp. 479-486
A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation
Authors: Kamp, GA Mul, D Waelkens, JJJ Jansen, M De Waal, HADV Verhoeven-Wind, L Frolich, M Oostdijk, W Wit, JM
Citation: Ga. Kamp et al., A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation, J CLIN END, 86(7), 2001, pp. 2969-2975
The effect of pubertal delay by GnJRH agonist in GH-deficient children on final height
Authors: Mul, D Wit, JM Oostdijk, W Van den Broeck, J
Citation: D. Mul et al., The effect of pubertal delay by GnJRH agonist in GH-deficient children on final height, J CLIN END, 86(10), 2001, pp. 4655-4656
Final height after gonadotrophin releasing hormone agonist treatment for central precocious puberty: The Dutch experience
Authors: Mul, D Oostdijk, W Otten, BJ Rouwe, C Jansen, M Delemarre-van de Waal, HA Waelkens, JJJ Drop, SLS
Citation: D. Mul et al., Final height after gonadotrophin releasing hormone agonist treatment for central precocious puberty: The Dutch experience, J PED END M, 13, 2000, pp. 765-772
Auxological and biochemical evaluation of pubertal suppression with the GnRH agonist leuprolide acetate in early and precocious puberty
Authors: Mul, D Keizer-Schrama, SMPFD Oostdijk, W Drop, SLS
Citation: D. Mul et al., Auxological and biochemical evaluation of pubertal suppression with the GnRH agonist leuprolide acetate in early and precocious puberty, HORMONE RES, 51(6), 1999, pp. 270-276
Tumor markers in retinoblastoma
Authors: Mul, D Schouten-van Meeteren, AYN van Kamp, GJ Tan, KEWP
Citation: D. Mul et al., Tumor markers in retinoblastoma, MED PED ONC, 32(2), 1999, pp. 146-147
Risultati: 1-12 |